PierianDx to Participate in 2nd International Precision Oncology and Experimental Therapeutics ‘POET’ Congress in Canada
by Josh Forsythe, on March 16, 2018
On April 5 and 6 oncology leaders will convene in Calgary, Alberta to participate in the 2nd International Precision Oncology and Experimental Therapeutics (POET) Congress. The annual meeting supports the education arm of the POET Congress research program that works to incorporate novel biomarker-driven phase I clinical trials research into practical routine cancer management. The goal of the congress is to accelerate education and knowledge dissemination of the most current novel interrogative-based approaches that drive precision oncology forward.
We will attend and feature our Clinical Genomics WorkSpace™ (CGW) platform. CGW is our unique, integrated workspace for genomic analytics, classification, interpretation and reporting. Driven by the PierianDx KnowledgeSpace, CGW provides end-to-end workflow from sample to report that seamlessly integrates with patient medical records and lab information systems.
For more information on the POET Congress event, please visit: http://poet-calgary.ca
- Image retrieved from http://poet-calgary.ca.